Crossref
Breast Cancer Management with Melanie E Royce: BOLERO-4 Phase II Trial of First-Line Everolimus Plus Letrozole in ER + , HER2 - Advanced Breast Cancer
Breast Cancer Management · 2016
DOI: 10.2217/bmt-2017-0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Management, 2016. Verfasst von Melanie E Royce. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Institutes of Health
Zitieren
APA
Royce, M. E. (2016). Breast Cancer Management with Melanie E Royce: BOLERO-4 Phase II Trial of First-Line Everolimus Plus Letrozole in ER + , HER2 - Advanced Breast Cancer. Breast Cancer Management. https://doi.org/10.2217/bmt-2017-0001
Vancouver
Royce ME. Breast Cancer Management with Melanie E Royce: BOLERO-4 Phase II Trial of First-Line Everolimus Plus Letrozole in ER + , HER2 - Advanced Breast Cancer. Breast Cancer Management. 2016. doi:10.2217/bmt-2017-0001
BibTeX
@article{Royce2016,
author = {Royce, Melanie E},
title = {Breast Cancer Management with Melanie E Royce: BOLERO-4 Phase II Trial of First-Line Everolimus Plus Letrozole in ER + , HER2 - Advanced Breast Cancer},
journal = {Breast Cancer Management},
year = {2016},
doi = {10.2217/bmt-2017-0001}
}
EUVIMED